Health, Vaccines, Lyme Disease, FDA, Medicine.
the public health agency responsible for recommending its use issued an ambiguous recommendation, saying that people “can use” the vaccine, rather than “must use,” says Poland. But the biggest roadblock stemmed from concerns that the vaccine caused an autoimmune reaction in some vaccine recipients.